Dr. Arvinder Singh Soin

Chairman

39 Years of Experience

HPB and Liver Transplant Surgeon

MBBS, MS, FRCS, FRCP

Reg. No.:5980, Medical Council of India

Medanta - The Medicity Hospital, Gurgaon

English

Consultation Fee ₹ 2000

Book an Appointment

About Dr. Arvinder Singh Soin

Padma Shri recipient Dr. A S Soin is an extremely renowned Liver Transplant Surgeon with over 39 years of experience.
He has performed over 12000 intricate surgeries encompassing liver, gall bladder, and bile duct procedures.
Leading a highly skilled team, he boasts a remarkable 95% success rate, averaging 25-30 successful transplants monthly.
With an extensive background, Dr. Soin has conducted over 2500 liver transplants, setting a national record.
He leads India's largest and most successful liver transplant programs at Medanta The Medicity.
Dr. Soin's groundbreaking contributions have been instrumental in establishing liver transplantation as a viable medical practice in India.
His educational qualifications include MBBS and MS from All India Institute of Medical Sciences, New Delhi, in 1985 and 1989, respectively.
He has played a pivotal role in training numerous liver transplant teams across the country, cementing his status as a leader in the field.
He is an esteemed member of various organizations including Association of Surgeons of India, British Transplantation Society, the Royal College of Surgeons of Edinburgh (RCSED), Royal College of Physicians and Surgeons of Glasgow (RCPSG), Indian Society of Nephrology (ISN), etc.

Book Your Appointment With Dr. Arvinder Singh Soin

Get a Treatment Plan Within 1 Hour

Name*

Mobile Number*

Is the above number on WhatsApp? *

Yes

Query

Education

MBBS, All India Institute of Medical Sciences, New Delhi, 1985
MS, All India Institute of Medical Sciences, New Delhi, 1989
FRCS (General Surgery), Royal College of Surgeon of Edinburgh, UK, 1992
Royal College of Physicians and Surgeons (RCPS), Glasgow, 1993
FRCS (General Surgery), Intercollegiate Board in General Surgery, 1997

Training & Certificates

Rotating Internship, All India Institute of Medical Sciences (AIIMS), New Delhi, 1986

Past Experience

enior Consultant, Sir Ganga Ram Hospital, 2010
Visiting Fellowship, Asan Medical Centre, 2000
Senior Consultant, Apollo Hospital, 2001
Senior Registrar, Addenbrooke's Hospital, 1998
Visiting Fellowship, Kyoto University, 1997
Registrar, Addenbrooke's Hospital, 1995
SHO / Fellow, Queen Elizabeth Hospital, University of Birmingham, 1993
Senior Resident, All India Institute of Medical Sciences (AIIMS), New Delhi, 1992

Awards

MT India Healthcare Award - 2016
MSOSA Award for Excellence - 2014
Doc n Doc Award for Excellence in Liver Transplantation - 2014
DMA Distinguished Services Award - 2013
E- medinews award - 2012
RD Birla - 2011
Swastha Bharat Samman - 2011
Padma Shri by the President of India - 2010
Achievements listed in Limca Book of Records - 2010
Achievements listed in Limca Book of Records - 2009
Achievements listed in Limca Book of Records - 2008
Medindia Oration and Medindia Award - 2008
Listed in Limca Book of Records - 2007
Awarded British Transplantation Society Bursary - 1997
Awarded research grant - 1996
Awarded British Transplantation Society Bursary - 1994
DMA Award - 1990

Associations/Membership

Association of Surgeons of India
British Transplantation Society
The Royal College of Surgeons of Edinburgh (RCSED)
Royal College of Physicians and Surgeons of Glasgow (RCPSG)
Indian Society of Organ Transplantation (ISOT)
Indian Society of Gastroenterology
Indian Association of Surgical Gastroenterology
Indian Society of Nephrology (ISN)
Asian Society of Organ Transplantation International Society of Liver Transplantation

Paper Published

Dr. Arvinder Singh Soin has published over 183 papers, some of which are mentioned below:

Prevalence of Modifiable Risk Factors for de novo Malignancies After Living Donor Liver Transplantation, 2024
CMV duodenitis causing persistent hypoalbuminemia and ascites after liver transplantation, 2024
Hilar Anatomy in 3035 Living Liver Donors: A Novel Classification for Donor Surgery and Suitability, Hepatic Surgeries, and Hepatobiliary Interventions, 2023
Post-transplant Non-alcoholic Fatty Liver Disease and Metabolic Syndrome After Living Donor Liver Transplantation in Indians, 2023
Metabolic dysfunction-associated steatotic liver disease: Where does non-alcoholic fatty liver disease in liver transplant recipients fit in this new definition? 2023
2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations, 2023
Atezolizumab and Bevacizumab for Treatment of Patients With Unresectable / Non-transplantable Advanced Hepatocellular Carcinoma: A Real-World Single Center Experience from North India, 2023
Postoperative Day 7 serum creatinine and serum bilirubin levels predict mortality in living donor liver transplantation recipients with early allograft dysfunction, 2023
Safety and Efficacy of Dual PPAR- Alpha Agonist, Saroglitazar, in Management of NAFLD with Diabetes and/or Dyslipidemia in Liver Transplant Recipients, 2023
Post-transplant non-alcoholic fatty liver disease and metabolic syndrome after living donor liver transplantation in Indians, 2023
Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference, 2023
Does the total robotic approach compromise recipient outcomes with liver graft with complex anatomy or extremes of weight compare to open right donor hepatectomy? 2023
Metabolic dysfunction-associated steatotic liver disease: Where does non-alcoholic fatty liver disease in liver transplant recipients fit in this new definition? 2023
National Liver Allocation Policy (N-LAP) - Consensus document by the Liver Transplantation Society of India for a nationally uniform system of allocation of deceased donor liver grafts, 2022
Which recipient pretransplant factors, such as MELD, renal function, sarcopenia, and recent sepsis, influence suitability for and outcome after living donor liver transplantation? – A systematic review of the literature and expert panel recommendations, 2022
Evaluation of the Intention-to-Treat Benefit of Living Donation in Patients With Hepatocellular Carcinoma Awaiting a Liver Transplant, 2021
Articles Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19- associated cytokine release syndrome (COVINGTON): an open-label, multicentre, randomized, controlled, phase 3 trial, 2021
Reply to Comment: A Worldwide Survey of Live Liver Donor Selection Policies at 24 Centers With a Combined Experience of 19 009 Adult Living Donor Liver Transplants, 2021
Safety assessment of RhD-positive red cell transfusion in RhD-negative liver-transplant recipients: Single-centre report from India, 2020
Liver Transplantation Society of India Guidelines for the Management of Acute Liver Injury Secondary to Yellow Phosphorus–Containing Rodenticide Poisoning Using the Modified Delphi Technique of Consensus Development, 2020
Pediatric liver transplantation in severe hepatopulmonary syndrome and use of inhaled nitric oxide for post?transplant hypoxemia–a single center experience, 2020
Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of Two Randomized Controlled Trials, 2020
An international multicentre study of protocols for liver transplantation during a pandemic: A case for quadripartite equipoise, 2020
Identification of an Upper Limit of Tumor Burden for Downstaging in Candidates with Hepatocellular Cancer Waiting for Liver Transplantation: A West-East Collaborative Effort, 2020
Factors Associated With Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation: Unanswered Questions, 2019
Predictors of De Novo Non-alcoholic Fatty Liver Disease After Liver Transplantation: Many Unanswered Questions, 2019
A Worldwide Survey of Live Liver Donor Selection Policies at 24 Centers With a Combined Experience of 19 009 Adult Living Donor Liver Transplants, 2018
A Retrospective Comparative Study of Venous versus Non-Ringed Expanded Polytetrafluoroethylene (e-PTFE) Extension Grafts for Anterior Sector Outflow Reconstruction in Right Lobe Living Donor Liver Transplantation, 2018
Proposal for a Worldwide Usable Score for the Prediction of Recurrence and Intention-to-Treat Survival after Liver Transplantation in Patients with Hepatocellular Cancer: A West-East Analysis on 1,903 Patients, 2018
Good Outcome of Living Donor Liver Transplantation for Severe Alcoholic Hepatitis not Responding to Medical Management: a Single Center Experience of 39 Patients, 2018
4. Outcome of living donor liver transplantation between genetically related and unrelated donors: experience of 1372 adult living donor liver transplantations from a single center, 2018
Renal Function Outcomes with Everolimus Plus Reduced-Exposure Tacrolimus in de Novo Living Donor Liver Transplantation: 24-month results from the H2307 study,l 2018
An Intention-to-Treat Competing-Risk Model for Candidates with Hepatocellular Cancer Awaiting Liver Transplantation, 2018
Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study. 2017
Survey Results of the Expert Meeting on Laparoscopic Living Donor Hepatectomy and Literature Review, 2017
Efficacy And Safety of Sofosbuvir Based Regimens For Treatment of Hepatitis C Recurrence After Living Donor Liver Transplantation: An Experience From India, 2017
Living Donor Liver Transplantation for Severe Alcoholic Hepatitis Not Responding to Medical Management: An Experience of 31 Patients, 2017
High MELD score does not adversely affect the outcome of Living Donor Liver Transplantation: Experience in 1000 recipients, 2017
Results of Portosystemic Shunt Embolization in Selected Patients with Cirrhosis and Recurrent Hepatic Encephalopathy, 2017
Results of Portosystemic Shunt Embolization in Selected Patients with Cirrhosis and Recurrent Hepatic Encephalopathy, 2017
(D+10) MELD as a Novel Predictor of Patient and graft Survival after Adult to Adult Living Donor Liver Transplantation, 2017
Good outcome of living donor liver transplantation in drug-induced acute liver failure: A single-center experience, 2017
Impact of endoscopic ultrasound-guided fine-needle aspiration in prospective liver transplant recipients with hepatocellular carcinoma and lymphadenopathy, 2016
Impact and safety of endoscopic ultrasound-guided fine needle aspiration on patients with cirrhosis and pyrexia of unknown origin in India, 2016
Innovative Approach of Using Esophageal Stent for Refractory Post-Band Ligation Esophageal Ulcer Bleed Following Living Donor Liver Transplantation, 2016
Genotype 3 and higher low-density lipoprotein levels are predictors of good response to treatment of recurrent hepatitis C following living donor liver transplantation, 2015
CMV Infection in Living Donor Liver Transplant Recipients Significantly Impacts the Early Post-Transplant Outcome: A Large Single Center Experience, 2015
Everolimus with reduced tacrolimus versus standard tacrolimus in living-donor liver transplant recipients: Baseline data from the H2307 Study, 2015
Sarcopenic Obesity With Metabolic Syndrome: A Newly Recognized Entity Following Living Donor Liver Transplantation, 2015
Successful Donation After Rapid Reversal of Liver Steatosis with Life Style Modification in Highly Motivated Donors in Living Donor Liver Transplant Program, 2014
Low Dose, Short Term HBIG with High Genetic Barrier Antivirals, Is Associated with Minimal Risk of Hepatitis B Recurrence after Liver Transplantation., 2013
Smoothing the path: Reducing biliary complications, addressing small?for?size syndrome, and making other adaptations to decrease the risk for living donor liver transplant recipients, 2012
Accuracy of T-2 Weighted Magnetic Resonance Cholangiopancreatography in Evaluation of Biliary Anatomy in Living Liver Donors, 2011
Graft to Recipient Weight Ratio Analysis of 414 Consecutive Living Donor Liver Transplants: How Much Can the Bar Be Lowered?, 2010
Twenty-Two Month Liver Recipient with Maple Syrup Urine Disease Donates Liver to Another Toddler: A Report on the World's Youngest Domino Pair, 2010
End-stage non-alcoholic fatty liver disease: Evaluation of pathomorphological features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program, 2009
Transabdominal gastroesophageal devascularization without transection for bleeding varices: Results and indicators of prognosis, 2007